Last updated on April 23, 2014 at 16:13 EDT

Latest Natco Pharma Stories

2012-03-13 11:13:16

India´s government ended Bayer´s monopoly on a patented cancer drug on Monday, and has permitted a local pharmaceutical to manufacturer a less expensive generic version of the drug under a new law aimed at keeping costs affordable. The government allowed Natco Pharma to make and sell Nexavar, a kidney and liver cancer treatment drug that Bayer Corp. had been selling in India for about $5,600 per month, to Indian residents for $176 for a 120-tablet pack. Bayer´s patent on...